{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:18Z","timestamp":1789055238065,"version":"build-2803163510"},"reference-count":53,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.15.04344","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:59:01Z","timestamp":1764921541000},"source":"Crossref","is-referenced-by-count":1,"title":["Global burden and inequalities of drug use disorders from 1990 to 2021 with projections to 2036"],"prefix":"10.7189","volume":"15","author":[{"given":"Fuxin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Xue","sequence":"additional","affiliation":[{"name":"Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Biological and Food Engineering, Changshu Institute of Technology, Changshu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Qiao","sequence":"additional","affiliation":[{"name":"School of Public Health, Health Science Center, Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Public Health, Health Science Center, Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Drug Addiction Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4223","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"key-10.7189\/jogh.15.04344-202512040930-R1","doi-asserted-by":"publisher","first-page":"103677","DOI":"10.1016\/j.ajp.2023.103677","article-title":"Prevalence, incidence, deaths, and disability adjusted life-years of drug use disorders for 204 countries and territories during the past 30 years.","volume":"86","author":"Shen","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1186\/s12889-024-19142-0","article-title":"Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study.","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"5","author":"GBD 2016 Alcohol and Drug Use Collaborators","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R6","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2023. Vienna, Austria: UNODC; 2023. Available: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R7","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. Geneva, Switzerland: World Health Organization; 2024. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240096745. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R8","doi-asserted-by":"publisher","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States.","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R9","first-page":"100557","article-title":"Opioid crisis: addiction, overprescription, and insuf\ufb01cient primary prevention.","volume":"23","author":"The Lancet Regional Health-Americas","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R10","doi-asserted-by":"publisher","first-page":"102985","DOI":"10.1016\/j.eclinm.2024.102985","article-title":"Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study.","volume":"79","author":"Kim","year":"2024","journal-title":"EClinicalMedicine"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R11","doi-asserted-by":"publisher","first-page":"e2322303","DOI":"10.1001\/jamanetworkopen.2023.22303","article-title":"Trends in opioid toxicity-related deaths in the US before and after the start of the COVID-19 pandemic, 2011-2021.","volume":"6","author":"Gomes","year":"2023","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24-30, 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R13","unstructured":"United Nations Office on Drugs and Crime. COVID-19 and the drug supply chain: From production and trafficking to use. Vienna, Austria: UNODC; 2020. Available: https:\/\/www.unodc.org\/documents\/data-and-analysis\/covid\/Covid-19-and-drug-supply-chain-Mai2020.pdf. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R14","doi-asserted-by":"publisher","first-page":"25971","DOI":"10.1038\/s41598-025-11266-6","article-title":"Global burden of substance use disorders in adolescents and young adults aged 10-24 years from 1990 to 2021.","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R15","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1186\/s12889-025-22814-0","article-title":"Global burden and trend of substance use disorders, self-harm, and interpersonal violence from 1990 to 2021, with projection to 2040.","volume":"25","author":"An","year":"2025","journal-title":"BMC Public Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R16","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1186\/s12889-025-23283-1","article-title":"Global, regional, and national burden of opioid use disorder from 1990 to 2021: a statistical analysis of incidence, mortality, and disability-adjusted life years.","volume":"25","author":"Fang","year":"2025","journal-title":"BMC Public Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R17","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Results. 2022. Available: https:\/\/vizhub.healthdata.org\/gbd-results\/. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R18","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD 2021 cause and ICD code mappings. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2024. Available: https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2021-cause-icd-code-mappings. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0140-6736(16)31467-2","article-title":"Measuring the health-related sustainable development goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.","volume":"388","author":"GBD 2015 SDG Collaborators","year":"2016","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R20","unstructured":"United Nations Office on Drugs and Crime (UNODC). World Drug Report 2022. United Nations publication; 2022. Available: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2022.html. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R21","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2022: Trends and Developments. Luxembourg: Publications Office of the European Union; 2022. Available: https:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2022_en. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R22","doi-asserted-by":"publisher","first-page":"11782218231160014","DOI":"10.1177\/11782218231160014","article-title":"Comparing COVID-19-related morbidity and mortality between patients with and without substance use disorders: a retrospective cohort study.","volume":"17","author":"McLaughlin","year":"2023","journal-title":"Subst Abuse"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R23","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2021 national survey on drug use and health. Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2023. Available: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt39443\/2021NSDUHFFRRev010323.pdf. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2006.01.008","article-title":"Sex differences in striatal dopamine release in healthy adults.","volume":"59","author":"Munro","year":"2006","journal-title":"Biol Psychiatry"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/jclp.22159","article-title":"Emotion expression and substance use in newly parenting adolescents and young adults.","volume":"71","author":"Desrosiers","year":"2015","journal-title":"J Clin Psychol"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev-clinpsy-032511-143109","article-title":"Emotion regulation and psychopathology: the role of gender.","volume":"8","author":"Nolen-Hoeksema","year":"2012","journal-title":"Annu Rev Clin Psychol"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jadohealth.2023.11.018","article-title":"Associations of adolescent school social networks, gender norms, and adolescent-to-young adult changes in male gender expression with young adult substance use.","volume":"74","author":"Glasser","year":"2024","journal-title":"J Adolesc Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy.","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R30","doi-asserted-by":"publisher","first-page":"e2036687","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US Opioid Epidemic, 2007-2018.","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R31","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/1556-4029.14712","article-title":"Fentanyl-related substance scheduling as an effective drug control strategy.","volume":"66","author":"Weedn","year":"2021","journal-title":"J Forensic Sci"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R32","unstructured":"National Institute on Drug Abuse. Mental Health. Bethesda, Maryland, USA: National Institutes of Health, U.S. Department of Health and Human Services; 2023. Available: https:\/\/nida.nih.gov\/research-topics\/mental-health. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R34","unstructured":"Standing Committee of the National People's Congress. Anti-Drug Law of the People's Republic of China. Adopted 29 December 2007, effective 1 June 2008. Available: https:\/\/flk.npc.gov.cn\/detail?id=2c909fdd678bf17901678bf64d550393. Accessed: 16 May 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1477-7517-7-4","article-title":"The Chinese government\u2019s response to drug use and HIV\/AIDS: a review of policies and programs.","volume":"7","author":"Li","year":"2010","journal-title":"Harm Reduct J"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R36","unstructured":"Ministry of Public Security of the People\u2019s Republic of China. China Drug Situation Report 2024. Beijing, China: Ministry of Public Security of the People\u2019s Republic of China; 2025. Available: https:\/\/www.mps.gov.cn\/n2255079\/n6865805\/n7355741\/n7355780\/c10114656\/content.html. Accessed: 27 September 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R37","unstructured":"State Council of the People\u2019s Republic of China. Regulations on Drug Rehabilitation. Beijing, China: State Council of the People's Republic of China; 2011. Available: https:\/\/www.gov.cn\/zhengce\/zhengceku\/2011-06\/27\/content_6147.htm. Accessed: 27 September 2025."},{"key":"key-10.7189\/jogh.15.04344-202512040930-R38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1747-597X-9-15","article-title":"Integration of substance use disorder services with primary care: health center surveys and qualitative interviews.","volume":"9","author":"Urada","year":"2014","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1176\/appi.ps.202000183","article-title":"Integrating mental health and addiction treatment into general medical care: the role of policy.","volume":"71","author":"McGinty","year":"2020","journal-title":"Psychiatr Serv"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R40","doi-asserted-by":"publisher","first-page":"e2328627","DOI":"10.1001\/jamanetworkopen.2023.28627","article-title":"Integrating opioid use disorder treatment into primary care settings.","volume":"6","author":"Austin","year":"2023","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R41","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.dadr.2023.100152","article-title":"A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care.","volume":"7","author":"Adeniran","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R42","doi-asserted-by":"publisher","first-page":"e59791","DOI":"10.2196\/59791","article-title":"The evolution of health information technology for enhanced patient-centric care in the United States: data-driven descriptive study.","volume":"26","author":"Barker","year":"2024","journal-title":"J Med Internet Res"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/YCO.0000000000001017","article-title":"Developing a sentinel network for illicit substance use monitoring in Spain: a qualitative approach to key determinants.","volume":"38","author":"Varela-Lema","year":"2025","journal-title":"Curr Opin Psychiatry"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R44","doi-asserted-by":"publisher","first-page":"e004685","DOI":"10.1136\/bmjgh-2020-004685","article-title":"Learning from LMICs: best practices for leveraging sentinel surveillance systems to track the US COVID-19 pandemic.","volume":"5","author":"Root","year":"2020","journal-title":"BMJ Glob Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R45","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1111\/add.16623","article-title":"School-based interventions targeting substance use among young people in low-and-middle-income countries: A scoping review.","volume":"119","author":"Cadri","year":"2024","journal-title":"Addiction"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12954-020-00445-5","article-title":"Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.","volume":"17","author":"Wilkinson","year":"2020","journal-title":"Harm Reduct J"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11920-013-0414-z","article-title":"Treating substance use disorders in the criminal justice system.","volume":"15","author":"Belenko","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12888-024-05734-y","article-title":"Effectiveness of substance use disorder treatment as an alternative to imprisonment.","volume":"24","author":"Virtanen","year":"2024","journal-title":"BMC Psychiatry"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R49","first-page":"640","article-title":"Opioid substitution treatment, relapse and addiction-related outcomes in prison setting and after release: a longitudinal study.","volume":"41","author":"Gei\u00dfels\u00f6der","year":"2024","journal-title":"Nordisk Alkohol Nark"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40352-025-00317-9","article-title":"Medication for opioid use disorder service delivery in carceral facilities: update and summary report.","volume":"13","author":"Berk","year":"2025","journal-title":"Health Justice"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13031-022-00466-w","article-title":"Primary Healthcare Quality in Conflict and Fragility: a subnational analysis of disparities using Population Health surveys.","volume":"16","author":"Ramadan","year":"2022","journal-title":"Confl Health"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R52","doi-asserted-by":"crossref","unstructured":"Hoogeveen J, Pape U, editors. Data collection in fragile states: innovations from Africa and beyond. Cham, Switzerland: Springer, 2020. Available: https:\/\/link.springer.com\/book\/10.1007\/978-3-030-25120-8?utm_source. Accessed: 27 September 2025.","DOI":"10.1007\/978-3-030-25120-8"},{"key":"key-10.7189\/jogh.15.04344-202512040930-R53","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Survey on Drug Use and Health (NSDUH) - Health, United States: Sources and definitions. Available: https:\/\/www.cdc.gov\/nchs\/hus\/sources-definitions\/nsduh.htm. Accessed: 27 September 2025."}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2025\/jogh-15-04344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:59:06Z","timestamp":1764921546000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2025\/jogh-15-04344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7189\/jogh.15.04344","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"04344"}}